185 related articles for article (PubMed ID: 2966247)
1. Synthesis and pharmacological evaluation of 5,6-exo-epoxy-7-oxabicyclo[2.2.1]heptane derivatives.
Das J; Vu T; Harris DN; Ogletree ML
J Med Chem; 1988 May; 31(5):930-5. PubMed ID: 2966247
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro activity of various derivatives of a novel thromboxane receptor antagonist, (+/-)-(5Z)-7-[3-endo-[(phenylsulfonyl)amino]bicyclo[2.2.1] hept-2-exo-yl]heptenoic acid.
Narisada M; Ohtani M; Watanabe F; Uchida K; Arita H; Doteuchi M; Hanasaki K; Kakushi H; Otani K; Hara S
J Med Chem; 1988 Sep; 31(9):1847-54. PubMed ID: 2970551
[TBL] [Abstract][Full Text] [Related]
3. 7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors.
Naka M; Mais DE; Morinelli TA; Hamanaka N; Oatis JE; Halushka PV
J Pharmacol Exp Ther; 1992 Aug; 262(2):632-7. PubMed ID: 1386885
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and in vitro activity of stereoisomers of a novel thromboxane receptor antagonist, (+-)-(5Z)-7-[3-endo-[(phenylsulfonyl)amino]bicyclo [2.2.1]hept-2-exo-yl]heptenoic acid.
Ohtani M; Narisada M
J Med Chem; 1990 Mar; 33(3):1027-31. PubMed ID: 2137879
[TBL] [Abstract][Full Text] [Related]
5. Interphenylene 7-oxabicyclo[2.2.1]heptane oxazoles. Highly potent, selective, and long-acting thromboxane A2 receptor antagonists.
Misra RN; Brown BR; Sher PM; Patel MM; Hall SE; Han WC; Barrish JC; Kocy O; Harris DN; Goldenberg HJ
J Med Chem; 1993 May; 36(10):1401-17. PubMed ID: 8496908
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a thromboxane A2/prostaglandin H2 receptor in guinea pig lung membranes using a radioiodinated thromboxane mimetic.
Saussy DL; Mais DE; Dubé GP; Magee DE; Brune KA; Kurtz WL; Williams CM
Mol Pharmacol; 1991 Jan; 39(1):72-8. PubMed ID: 1824791
[TBL] [Abstract][Full Text] [Related]
7. [Effect of a new thromboxane A2 antagonist, S-145, on platelet aggregation].
Kakushi H; Shike T; Uchida K
Nihon Yakurigaku Zasshi; 1989 Mar; 93(3):171-8. PubMed ID: 2731807
[TBL] [Abstract][Full Text] [Related]
8. Stereocontrolled synthesis of 7-oxabicyclo (2.2.1) heptane prostaglandin analogs as thromboxane A2 antagonists.
Sprague PW; Heikes JE; Harris DN; Greenberg R
Adv Prostaglandin Thromboxane Res; 1980; 6():493-6. PubMed ID: 7189952
[No Abstract] [Full Text] [Related]
9. Aza-substituted omega-side-chain modifications of 7-oxabicyclo[2.2.1]heptane thromboxane A2 receptor antagonists: structure-activity relationships.
Nakane M; Reid JA; Haslanger MF; Garber DP; Harris DN; Ogletree ML; Greenberg R
Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():291-3. PubMed ID: 3004140
[No Abstract] [Full Text] [Related]
10. Inhibition of ligand binding to thromboxane A2/prostaglandin H2 receptors by diethylpyrocarbonate. Protection by receptor ligands and reversal by hydroxylamine.
Schrör K; Davis-Bruno K; Halushka PV
Biochem Pharmacol; 1995 Mar; 49(7):921-7. PubMed ID: 7741764
[TBL] [Abstract][Full Text] [Related]
11. Antagonistic actions of S-145 on vascular and platelet thromboxane A2 receptors.
Mihara S; Hara S; Ueda M; Ide M; Fujimoto M
Eur J Pharmacol; 1989 Nov; 171(2-3):179-87. PubMed ID: 2533558
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and in vitro effects on platelets and vascular smooth muscle of S-145, a novel thromboxane receptor antagonist.
Narisada M; Ohtani M; Watanabe F; Uchida K; Arita H; Doteuchi M; Ueda M; Hanasaki K; Kakushi H; Otani K
Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():659-62. PubMed ID: 2526555
[No Abstract] [Full Text] [Related]
13. Pharmacological characterization of potent, long-acting thromboxane receptor antagonists, SQ 33,261 and SQ 33,552.
Harris DN; Michel IM; Goldenberg HJ; Hartl KS; Allen GT; Steinbacher TE; Schumacher WA; Han WC; Hall SE; Floyd DM
J Pharmacol Exp Ther; 1992 Apr; 261(1):131-7. PubMed ID: 1532833
[TBL] [Abstract][Full Text] [Related]
14. [Effect of (+)-S-145 calcium salt dihydrate, an orally active antagonist of the thromboxane A2/prostaglandin endoperoxide receptor, on platelet aggregation].
Kakushi H; Shike T; Hayasaki Y; Arita H; Uchida K
Nihon Yakurigaku Zasshi; 1991 Aug; 98(2):113-20. PubMed ID: 1916541
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and structure-activity relationship studies of cytotoxic epoxide derivatives of 7-oxabicyclo[2.2.1]heptane.
Anderson WK; Dewey RH
J Med Chem; 1977 Feb; 20(2):306-8. PubMed ID: 836504
[TBL] [Abstract][Full Text] [Related]
16. Homologous desensitization of human platelet thromboxane A2/prostaglandin H2 receptors.
Okwu AK; Ullian ME; Halushka PV
J Pharmacol Exp Ther; 1992 Jul; 262(1):238-45. PubMed ID: 1378092
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of thromboxane receptor antagonists with bicyclo[3.1.0]hexane ring systems.
Kamata S; Haga N; Tsuri T; Uchida K; Kakushi H; Arita H; Hanasaki K
J Med Chem; 1990 Jan; 33(1):229-39. PubMed ID: 2136917
[TBL] [Abstract][Full Text] [Related]
18. 7-Oxabicyclo[2.2.1]heptyl carboxylic acids as thromboxane A2 antagonists: aza omega-chain analogues.
Nakane M; Reid JA; Han WC; Das J; Truc VC; Haslanger MF; Garber D; Harris DN; Hedberg A; Ogletree ML
J Med Chem; 1990 Sep; 33(9):2465-76. PubMed ID: 2391688
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vitro pharmacology of 7-oxabicyclo[2.2.1]heptane analogues of thromboxane A2/PGH2.
Sprague PW; Heikes JE; Gougoutas JZ; Malley MF; Harris DN; Greenberg R
J Med Chem; 1985 Nov; 28(11):1580-90. PubMed ID: 4067988
[TBL] [Abstract][Full Text] [Related]
20. Mechanism for homologous downregulation of thromboxane A2 receptors in cultured human chronic myelogenous leukemia (K562) cells.
Dorn GW
J Pharmacol Exp Ther; 1991 Oct; 259(1):228-34. PubMed ID: 1833525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
